ASX-Dividend-Report-Banner

Healthcare


 AI-Powered Lung Disease Diagnosis Achieves 96.57% Accuracy

AI-Powered Lung Disease Diagnosis Achieves 96.57% Accuracy

January 24, 2025 03:26 PM AEDT | By Team Kalkine Media

Highlights:,AI model achieves 96.57% accuracy in diagnosing respiratory diseases through lung ultrasound analysis.,The model provides visual explanati...

 Clarity Pharmaceuticals (ASX:CU6) Gains FDA Fast Track Status for PET Scan Imaging Agent

Clarity Pharmaceuticals (ASX:CU6) Gains FDA Fast Track Status for PE...

January 24, 2025 03:00 PM AEDT | By Team Kalkine Media

Highlights,Clarity Pharmaceuticals (ASX:CU6) secures FDA fast-track designation for its Cu-64 SAR-,bisPSMA,imaging agent targeting recurrent prostate...

 4DMedical (ASX:4DX) Expands Commercial Presence with Qscan Radiology Clinics Agreement

4DMedical (ASX:4DX) Expands Commercial Presence with Qscan Radiology...

January 24, 2025 02:02 PM AEDT | By Team Kalkine Media

Highlight:,4DMedical Ltd (ASX:4DX) secures a commercial agreement with,Qscan,Radiology Clinics for lung health assessment products.,The agreement mark...

 Clarity Pharmaceuticals (ASX: CU6) Rises 3.5% on FDA Fast Track Designation for 64Cu-SAR-bisPSMA

Clarity Pharmaceuticals (ASX: CU6) Rises 3.5% on FDA Fast Track Desi...

January 24, 2025 01:52 PM AEDT | By Team Kalkine Media

Highlights,Clarity Pharmaceuticals (ASX:CU6) share price up 3.5%, reaching AUD 4.20.,FDA grants Fast Track Designation for 64Cu-SAR-bisPSMA in prostat...

 Are ASX Healthcare Stocks Showing a New Trend?

Are ASX Healthcare Stocks Showing a New Trend?

January 24, 2025 11:00 AM AEDT | By Team Kalkine Media

Highlights,ASX health sector has recorded a modest upward trend with diverse share price fluctuations across various companies.,EBR Systems achieves a...

 We believe that Clarity Pharmaceuticals (ASX:CU6) is well-positioned financially to support its business growth.

We believe that Clarity Pharmaceuticals (ASX:CU6) is well-positioned...

January 24, 2025 09:30 AM AEDT | By Team Kalkine Media

Exploring Clarity Pharmaceuticals' Cash Position

 Dusk Group Tops the List of 3 ASX Penny Stocks

Dusk Group Tops the List of 3 ASX Penny Stocks

January 23, 2025 05:26 PM AEDT | By Team Kalkine Media

Boosted Optimism as ASX200 Reaches New Highs

 ASX Stocks Potentially Undervalued in January 2025

ASX Stocks Potentially Undervalued in January 2025

January 23, 2025 05:26 PM AEDT | By Team Kalkine Media

Australian Stock Market's Positive Swing and Undervalued Opportunities

 MedAdvisor (ASX:MDR) shares have fallen 66% in five years, losing AU$14 million last week.

MedAdvisor (ASX:MDR) shares have fallen 66% in five years, losing AU...

January 23, 2025 05:23 PM AEDT | By Team Kalkine Media

Analyzing MedAdvisor's (ASX:MDR) Journey: A Look at Long-Term Investment Insights

 Shares of Nanosonics Limited (ASX:NAN) Might Be Trading at 24% Below Their Estimated Intrinsic Value

Shares of Nanosonics Limited (ASX:NAN) Might Be Trading at 24% Below...

January 23, 2025 05:23 PM AEDT | By Team Kalkine Media

Nanosonics Limited (ASX:NAN) Valuation Analysis

 Potential for Additional Gains in SomnoMed Limited (ASX:SOM) Shares May Present Price Risks Following a 27% Surge

Potential for Additional Gains in SomnoMed Limited (ASX:SOM) Shares...

January 23, 2025 05:21 PM AEDT | By Team Kalkine Media

SomnoMed (ASX:SOM) Stock on the Rise: A Closer Look at Its Market Metrics

 Health Check: Once a minor player, Nanosonics now dominates the field.

Health Check: Once a minor player, Nanosonics now dominates the fiel...

January 23, 2025 11:00 AM AEDT | By Team Kalkine Media

Nanosonics Signals Strong Financial Growth Amid Biotech Developments

 Botanix Pharmaceuticals Reaches a Significant Milestone with Long Shortz

Botanix Pharmaceuticals Reaches a Significant Milestone with Long Sh...

January 23, 2025 11:00 AM AEDT | By Team Kalkine Media

Highlights:,Botanix Pharmaceuticals (BOT) secures a position in the ASX 300, reinforcing its growth trajectory.,The company remains dedicated to advan...

 Orthocell Ltd's (ASX:OCC) Global Expansion Strategy Gains Momentum with Strong Sales Growth for Remplir™

Orthocell Ltd's (ASX:OCC) Global Expansion Strategy Gains Momentum w...

January 22, 2025 12:36 PM AEDT | By Team Kalkine Media

Highlights,Orthocell,Ltd (,ASX:OCC,) expands,Remplir,™ into global markets, backed by strong sales growth.,The US market opportunity,valued,at ~US,$1....

 Compumedics Secures 5-Year Philips Contract for Somfit Sleep Device, Expands U.S. Market Presence

Compumedics Secures 5-Year Philips Contract for Somfit Sleep Device,...

January 22, 2025 12:10 PM AEDT | By Team Kalkine Media

Highlights,New 5-Year Agreement with Philips:,Compumedics will continue supplying its,Somfit device,to Philips' pharmacy-based sleep program in Austra...

 Cardiex (ASX:CDX) Pioneers Health Monitoring with CONNEQT Pulse Launch

Cardiex (ASX:CDX) Pioneers Health Monitoring with CONNEQT Pulse Laun...

January 22, 2025 11:00 AM AEDT | By Team Kalkine Media

Cardiex (ASX:CDX) Pioneers Health Monitoring with CONNEQT Pulse Launch

 Can Orthocell Revolutionize Regenerative Medicine Globally?

Can Orthocell Revolutionize Regenerative Medicine Globally?

January 22, 2025 11:00 AM AEDT | By Team Kalkine Media

Highlights,Accelerating international market entry for Remplir in the regenerative medicine sector.,Expanding presence in regions including Australia,...

 What’s Driving Pacific Edge, LTR Pharma, and Orthocell’s Latest ASX Developments?

What’s Driving Pacific Edge, LTR Pharma, and Orthocell’s Latest ASX...

January 22, 2025 11:00 AM AEDT | By Team Kalkine Media

Highlights:.,Pacific Edge (ASX:PEB),challenges a US decision impacting Medicare reimbursement for its bladder cancer diagnostic test, Cxbladder.,LTR P...

 Ready to Revolutionize Pediatric Neurological Treatments?

Ready to Revolutionize Pediatric Neurological Treatments?

January 22, 2025 11:00 AM AEDT | By Team Kalkine Media

Highlights,● Neurotech International (ASX:NTI) partners with RH Farma Dooel Skopje under a binding development agreement.,● The collaboration focuses...

 Can ISLA-101 Change the Fight Against Dengue Fever?

Can ISLA-101 Change the Fight Against Dengue Fever?

January 22, 2025 11:00 AM AEDT | By Team Kalkine Media

Highlights:,Island Pharmaceuticals completes enrolment for the phase 2b segment of the PROTECT trial.,The trial examines ISLA-101’s role in reducing d...

Recent Articles






Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.